Bayer AG MTN v.2023(2033/2033)
Type of financial instrument
Corporate Bond
Sub-Type
Health Care
Yield
3.88
Yield spread Bundesanleihe
1.0601
Tradable for private investors
Yes
Minimum amount tradeable unit
1,000.00
Maturity
26/05/2033
Interest Rate
4.625 %
Currency
Euro
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE / YIELD | 104.536 G / 3.88 | 0 Units |
| PRICE DETERMINATION TIME | 06/12/2026 / 09:47:48 PM | |
| DAILY VOLUME (NOMINAL) | 78,000 | |
| YIELD SPREAD | 1.0601 | |
| FIXINGPRICE | - | |
| DAILY HIGH / LOW | 104.786 | 104.304 |
| PREV. DAY'S PRICE | 104.28 | (06/11) |
| CHANGE DAY BEFORE | +0.26 | 0.25 % |
| 52 WEEK HIGH / LOW | 107.86 (08/05) | 102.825 (03/27) |
Master Data
| WKN | A351U1 |
| ISIN | XS2630111719 |
| SYMBOL | - |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Corporate Bond |
| SUB-TYPE | Health Care |
| ISSUER | Bayer AG |
| S&P RATING | Please log in to view this field |
| (TRADING) SEGMENT / TICKS | -/ - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| INTEREST RATE | 4.625 % |
| INTEREST RUN FROM | 26/05/2023 |
| NEXT INTEREST PAYMENT | 26/05/2027 |
| UNIT INTEREST FROM NOMINAL AMMOUNT | 0.266 % |
| TRADING CURRENCY / NOTATION | Euro/ Percent |
| NOMINAL CURRENCY | Euro |
| SETTLEMENT CURRENCY | Euro |
| QUOTATION | Continuous trading |
| ISSUING VOLUME | 1.50 Bil. |
| MINIMUM AMOUNT TRADEABLE UNIT | 1,000.00 |
| SMALLEST TRADEABLE UNIT | 1,000.00 |
| MATURITY | 26/05/2033 |
| MARKET MAKER | - |
| STEP UP/ DOWN WHEN RATING CHANGES | No |
| STEP UP FIXED AT ISSUE | No |
| STEP DOWN FIXED AT ISSUE | No |
| BOND CALLABLE BY THE ISSUER | Yes |
| BOND IS SUBORDINATED | No |
Description
Callable bond.
Tradability Information
Please log in to see the tradability information for this stock.Not registered yet? Create an account here.
Company profile
Bayer AG engages in the business of life science fields of healthcare and nutrition. It operates through the following segments: Crop Science, Pharmaceuticals, and Consumer Health. The Crop Science segment includes developing, producing, and marketing products in seeds and plant traits, crop protection, digital solutions, and customer services to promote sustainable agriculture. The Pharmaceuticals segment is involved in prescription products especially for cardiology and women’s health; specialty therapeutics in the areas of oncology, hematology, ophthalmology, and cell and gene therapy; diagnostic imaging equipment; and necessary contrast agents. The Consumer Health segment focuses on non-prescription products in the dermatology, nutritional supplements, digestive health, allergy, cough and cold, and pain and cardiovascular risk prevention categories. The company was founded by Friedrich Bayer and Johann Friedrich Westkott on August 1, 1863 and is headquartered in Leverkusen, Germany.